Lame duck Congress looks for swift approval of massive medical innovation bill
From the article:
(Tweet by Rachel E. Sachs) My 1st thoughts on today's draft of 21st Century Cures: some bad provisions are gone, some remain, & some to watch. http://blogs.harvard.edu/billofhealth/2016/11/25/the-newest-21st-century-cures-draft-moderates-but-doesnt-eliminate-controversy/
That’s just a small view into this almost one thousand page measure, which has a summary that runs 44 pages, while the table of contents for the legislation consumes almost 10 pages, which I have listed below.
Just reading through all of the programs, the grants, and the sheer volume of different issues, it’s obvious that this plan has been the subject of very heavy lobbying – and has all sorts of different provisions dealing with health and more.
Read the full article here.bioethics biotechnology fda health care finance health care reform health law policy pharmaceuticals rachel sachs regulation